| Zeotech Limited (ZEO) ORDINARY FULLY PAID |
Materials |
$160 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Oct 2025 9:28AM |
$0.088 |
$0.078 |
fallen by
11.36%
|
|
ZEO - Price-sensitive ASX Announcement
Full Release
Key Points
- Zeotech Limited completed a $13 million capital raise.
- Net cash outflow from operating activities was $1.172 million.
- Cash and cash equivalents at the end of the period were $2.905 million.
- A binding DSO kaolin offtake agreement was secured.
- The company is advancing the Toondoon Kaolin Project.
- A successful commercial-scale demonstration pour of AusPozz™ was conducted.
- No active mining production occurred during the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Southern Palladium Limited (SPD) ORDINARY FULLY PAID |
Materials |
$146 |
2025 Corporate Governance Statement
|
28 Oct 2025 9:27AM |
$1.030 |
$1.100 |
risen by
6.80%
|
|
| Chariot Resources Ltd (CC9) ORDINARY FULLY PAID |
Materials |
$12 |
Application for quotation of securities - CC9
|
28 Oct 2025 9:27AM |
$0.190 |
$0.055 |
fallen by
71.05%
|
|
| Breakthrough Minerals Limited (BTM) ORDINARY FULLY PAID |
Energy |
$33 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Oct 2025 9:26AM |
$0.235 |
$0.170 |
fallen by
27.66%
|
|
BTM - Price-sensitive ASX Announcement
Full Release
Key Points
- Completed soil sampling program at Errolls Gold Project highlighted prospectivity.
- Cash balance at the end of September 2025 quarter is approximately $1.68 million.
- Planning to commence RC drilling at Errolls Gold Project, Western Australia.
- High-grade gold acquisition at Errolls Gold Project within Barrambie Greenstone Belt.
- Historical mining at Errolls yielded approximately 5,230 ounces of gold.
- Net cash used in operating activities for the quarter was $147,000.
- Net cash used in investing activities was $241,000.
- Cash and cash equivalents at the end of the period were $1,687,000.
- Payments to related parties totaled $73,000 for the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Auris Minerals Limited (AUR) ORDINARY FULLY PAID |
Materials |
$23 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Oct 2025 9:26AM |
$0.019 |
$0.018 |
fallen by
5.26%
|
|
AUR - Price-sensitive ASX Announcement
Full Release
Key Points
- Cash balance at 30 September 2025 of ~$0.93 million.
- Secured $3.2 million via a strategic placement.
- Focus on base metals and gold exploration in the Bryah Basin.
- Total tenement portfolio covers approximately 245 km².
- Completed rock chip sampling at Morck Well Project.
- No production or development activities undertaken during the quarter.
- Net cash outflow of $236,000 for the quarter.
- Estimated 3.94 quarters of funding available.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MA Credit Income Trust (MA1) ORDINARY UNITS FULLY PAID |
- |
$547 |
Dividend/Distribution - MA1
|
28 Oct 2025 9:26AM |
$1.995 |
$1.955 |
fallen by
2.01%
|
|
| The Calmer Co International Limited (CCO) ORDINARY FULLY PAID |
Consumer Staple |
$7 |
Investor Presentation
|
28 Oct 2025 9:25AM |
$0.004 |
$0.002 |
fallen by
50%
|
|
CCO - Price-sensitive ASX Announcement
Full Release
Key Points
- Q1 FY26 sales reached a new record of $2.4 million.
- Total sales increased by 26% compared to Q4 FY25.
- Retail sales surged by 68%, driven by Coles and Woolworths.
- Wholesale revenue rose 30%, with innovative product offerings.
- US market sales up by 21%, aided by Amazon Marketplace performance.
- Net cash used in operations decreased by 39% to $597k.
- Cash on hand was $1.37 million, supported by convertible note funding.
- Company progressing towards break-even with strong global demand for kava.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kip McGrath Education Centres Limited (KME) ORDINARY FULLY PAID |
Consumer Discretionary |
$28 |
Update - Notification of buy-back - KME
|
28 Oct 2025 9:25AM |
$0.590 |
$0.530 |
fallen by
10.17%
|
|
| Excite Technology Services Limited (EXT) ORDINARY FULLY PAID |
Information Technology |
$15 |
Application for quotation of securities - EXT
|
28 Oct 2025 9:25AM |
$0.010 |
$0.007 |
fallen by
30%
|
|
| AVA Risk Group Limited (AVA) ORDINARY FULLY PAID |
Information Technology |
$11 |
Notification regarding unquoted securities - AVA
|
28 Oct 2025 9:25AM |
$0.078 |
$0.037 |
fallen by
52.56%
|
|
| 360 Capital Mortgage REIT (TCF) ORDINARY UNITS FULLY PAID |
Financials |
$52 |
Update - Notification of buy-back
|
28 Oct 2025 9:25AM |
$5.810 |
$5.790 |
fallen by
0.34%
|
|
| Syrah Resources Limited (SYR) ORDINARY FULLY PAID |
Materials |
$267 |
September 2025 Quarterly Activities and Cashflow Report
|
28 Oct 2025 9:25AM |
$0.375 |
$0.115 |
fallen by
69.33%
|
|
SYR - Price-sensitive ASX Announcement
Full Release
Key Points
- TRIFR of 1.1 at quarter end
- 26kt natural graphite produced at Balama
- 24kt natural graphite sold at US$625 per tonne
- Quarter-end cash balance of US$87 million
- A$70 million institutional placement completed
- Global EV sales grew by 28%
- US tariffs on Chinese imports affecting supply chain
- Chinese export controls on battery materials
- Focus on production and sales improvements
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| The Calmer Co International Limited (CCO) ORDINARY FULLY PAID |
Consumer Staple |
$7 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Oct 2025 9:24AM |
$0.004 |
$0.002 |
fallen by
50%
|
|
CCO - Price-sensitive ASX Announcement
Full Release
Key Points
- Record quarterly revenue of $2.4 million, a 26% increase QoQ.
- Net operating cash outflows reduced by 36% to $0.6 million.
- Cash receipts from customers totaled $2.1 million.
- Convertible note program raised $700k for inventory expansion.
- Strong retail performance in Australia with Coles and Woolworths.
- U.S. sales increased, led by Amazon Marketplace expansion.
- Ended the quarter with $1.37 million in cash.
- Focus on disciplined cost management and working capital investment.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gale Pacific Limited (GAP) ORDINARY FULLY PAID |
Consumer Discretionary |
$21 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Oct 2025 9:24AM |
$0.091 |
$0.075 |
fallen by
17.58%
|
|
GAP - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash used in operating activities was $3.7 million.
- First quarter sales of $40.2 million, down 4.5% from last year.
- U.S. operating model restructuring aims to save $3.1 million.
- Seasonality affects cash flow with peak trading in ANZ approaching.
- Inventory sell-in ahead of ERP launch impacted sales figures.
- Strategic initiatives update expected at the Annual General Meeting in November 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ariadne Australia Limited (ARA) ORDINARY FULLY PAID |
Industrials |
$93 |
Update - Notification of buy-back - ARA
|
28 Oct 2025 9:23AM |
$0.510 |
$0.480 |
fallen by
5.88%
|
|
| RareX Limited (REE) ORDINARY FULLY PAID |
Materials |
$16 |
More High Grade Gallium Extends Cummins Range Mineralisation
|
28 Oct 2025 9:23AM |
$0.036 |
$0.013 |
fallen by
63.89%
|
|
REE - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade gallium mineralization confirmed in Cummins Range.
- Gallium found alongside high-grade REE and scandium.
- Gallium could become a major revenue stream for Cummins Range.
- Re-assaying results show consistent gallium enrichment.
- Strategic importance of Cummins Range reinforced.
- Focus on optimizing gallium extraction processes.
- Cummins Range hosts significant multi-element resources.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| New Murchison Gold Limited (NMG) ORDINARY FULLY PAID |
Materials |
$511 |
September 2025 Quarterly Activities and Cashflow Reports
|
28 Oct 2025 9:22AM |
$0.028 |
$0.047 |
risen by
67.86%
|
|
NMG - Price-sensitive ASX Announcement
Full Release
Key Points
- NMG commenced gold production at Crown Prince Gold Mine in September 2025, marking its transition from developer to producer.
- A total of 31,047 tonnes of ore grading 3.34 g/t Au were trucked to Westgold Resources' Bluebird Gold Processing Plant.
- NMG completed a $12 million placement and $3 million share purchase plan as part of a $15m pre-mine development capital raising.
- NMG was included in the S&P/ASX All Ordinaries Index, reflecting increased market capitalisation and transition to gold producer status.
- High-grade drilling results confirmed extensions of mineralisation below the current pit at Crown Prince, supporting underground mining potential.
- Regional exploration across the 677km2 Abbotts Belt returned multiple high-grade gold intersections.
- NMG finished the September Quarter with $19.7 million cash and received $15.8 million for first month of gold-in-ore sales under their OPA.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Arafura Rare Earths Ltd (ARU) ORDINARY FULLY PAID |
Materials |
$1,366 |
Trading Halt
|
28 Oct 2025 9:22AM |
$0.375 |
$0.255 |
fallen by
32%
|
|
ARU - Price-sensitive ASX Announcement
Full Release
Key Points
- Arafura Rare Earths Ltd requested a trading halt on 28 October 2025.
- The trading halt is pending an announcement regarding a proposed capital raising.
- The halt will last until the announcement is made or trading resumes on 30 October 2025.
- Arafura Rare Earths Ltd is not aware of any reason why the trading halt should not be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID |
Health Care |
$27 |
Q1 FY26 Quarterly Investor Presentation & Webinar
|
28 Oct 2025 9:21AM |
$0.079 |
$0.038 |
fallen by
51.90%
|
|
MAP - Price-sensitive ASX Announcement
Full Release
Key Points
- Leveraging large databank and AI for precision biotherapeutics.
- Focus on strategic partnerships and commercialization pathways.
- Potential for significant deal precedents ranging from $1.5 to $11 billion.
- Pipeline includes preclinical and clinical validation data.
- Commercial strategies include live biotherapeutic products and next-gen probiotics.
- Aim to address chronic diseases with microbiome diagnostics.
- Microba is positioned within a $1.4 trillion healthcare disruption space.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Trajan Group Holdings Limited (TRJ) ORDINARY FULLY PAID |
Health Care |
$41 |
2025 Annual General Meeting Chair Address and Presentation
|
28 Oct 2025 9:21AM |
$0.800 |
$0.265 |
fallen by
66.88%
|
|
| AUB Group Limited (AUB) ORDINARY FULLY PAID |
Financials |
$3,719 |
Response to ASX Price Query
|
28 Oct 2025 9:20AM |
$35.980 |
$28.470 |
fallen by
20.87%
|
|
AUB - Price-sensitive ASX Announcement
Full Release
Key Points
- AUB Group Limited confirmed the receipt of a conditional, non-binding, indicative proposal from Arbutus Pte. Limited, affiliated with EQT AB, to acquire 100% of AUB's shares.
- The proposal involved a scheme of arrangement for a price of $45.00 cash per AUB share following a previous proposal of $43.00 per share.
- The recent trading in AUB's securities was potentially influenced by an article in the Australian Financial Review titled 'Underperforming AUB Group in crosshairs of private equity suitor'.
- AUB was initially relying on Listing Rule 3.1A to keep the proposal confidential as it related to incomplete negotiations.
- Upon discovering the media article, AUB requested a trading halt to pause securities trading.
- AUB confirmed compliance with ASX Listing Rule 3.1 and that responses were approved by its Disclosure Committee.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AdAlta Limited (1AD) ORDINARY FULLY PAID |
Health Care |
$8 |
Cleansing Notice
|
28 Oct 2025 9:20AM |
$0.004 |
$0.003 |
fallen by
25%
|
|
| AUB Group Limited (AUB) ORDINARY FULLY PAID |
Financials |
$3,719 |
Unsolicited Non-Binding Indicative Proposal to acquire AUB
|
28 Oct 2025 9:20AM |
$35.980 |
$28.470 |
fallen by
20.87%
|
|
AUB - Price-sensitive ASX Announcement
Full Release
Key Points
- AUB Group Limited received an unsolicited, non-binding indicative proposal from EQT to acquire 100% of AUB.
- The proposal offers AUB shareholders $45.00 cash per share, subject to conditions.
- A previous offer of $43.00 cash per share was made on 13 September 2025.
- The proposal is contingent on exclusivity, due diligence, board recommendation, and execution of a scheme implementation deed.
- AUB entered a confidentiality and exclusivity agreement with EQT, allowing due diligence access for six weeks from 8 October 2025.
- The exclusivity agreement contains no shop, no talk, and no due diligence restrictions with a fiduciary exception.
- The board emphasizes no guarantee of transaction completion and advises shareholders to take no immediate action.
- AUB has appointed Macquarie Capital as financial adviser and Allens as legal adviser.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IODM Limited (IOD) ORDINARY FULLY PAID |
Information Technology |
$79 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Oct 2025 9:20AM |
$0.165 |
$0.125 |
fallen by
24.24%
|
|
IOD - Price-sensitive ASX Announcement
Full Release
Key Points
- Record cash receipts of A$850k, 76% increase from previous corresponding period
- UK Education sector saw a 116% increase in cash receipts
- Successful strategy execution and value proposition of IODM Connect
- 31% reduction in net operational cash outflows
- Expansion and market penetration through profit-sharing and EI onboarding
- Engagement and integration efforts in USA, Canada, and Japan
- Prudent management of capital and cash flow
- Company received a R&D tax incentive of $682K in the second quarter
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID |
Health Care |
$27 |
Q1 FY26 Quarterly Activities Report & Appendix 4C
|
28 Oct 2025 9:20AM |
$0.079 |
$0.038 |
fallen by
51.90%
|
|
MAP - Price-sensitive ASX Announcement
Full Release
Key Points
- Q1 FY26 total revenue of $3.6 million, down 1% versus PCP.
- Growth product revenue increased by 151% to $1.9 million.
- Operating expenditures reduced by 26% in Q1 FY26.
- Cash reserves of $13.89 million as of 30 September 2025.
- Strong growth in core products MetaXplore and MetaPanel.
- Expecting $3 million from FY25 R&D Tax Incentive.
- Completed transition from legacy products to core growth products.
- Focus on expanding core product offerings and potential partnerships in therapeutics.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
